SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hyseq
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JF Quinnelly who wrote (3)3/9/1999 1:28:00 AM
From: John Starks   of 11
 
JF,

As far as I can tell they have no plans to license it out. I asked that very question in an email to the science officer but have gotten no response. Your inference is well taken: Does Hyseq have the structural support in place to develop a therapeutic product on its own? I'll post any response I receive.

Nanogen's technology is very exciting, indeed. The biomolecular machines are out of my league (off the stratosphere IMO), but their sequencing technology seems to allow them to analyze minute quantities of DNA--a clear advantage. Also, there is intense academic interest in the idea that we can manipulate enzymes into performing nano-scale mechanical functions, a field that Nanogen is pursuing. For example, one could imagine that we could take the enzyme responsible for twisting DNA into its correct topological configuration and instruct it to do the same for nanometer-scale fibers. I want to learn more about this technology and any interesting stuff that comes out of my travels I will be sure to post.

see you,
John

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News